Versant Ventures VI GP-GP, LLC, 10% Owner at Akero Therapeutics, Inc. (AKRO), sold 119,064 shares at $22.39 ($2.5M) on 2020-01-21, disclosed to the SEC on 2020-01-21.
Open-market sale of $2.5M AKRO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.72 | 22,489 | $443K | 17.8% |
| 2 | $19.72 | 22,489 | $443K | 17.8% |
| 3 | $20.09 | 11,103 | $223K | 9.0% |
| 4 | $20.09 | 11,103 | $223K | 9.0% |
| 5 | $21.78 | 8,091 | $176K | 7.1% |
| 6 | $21.78 | 8,091 |
| $176K |
| 7.1% |
| 7 | $22.39 | 17,849 | $400K | 16.1% |
| 8 | $22.39 | 17,849 | $400K | 16.1% |
| Total | $20.87 avg | 119,064 | $2.5M | 100% |
| Filing → |
| AKRO | SELL | 2020-01-09 | $2.1M | — | Filing → |
| AKRO | SELL | 2020-01-06 | $2.7M | — | Filing → |